We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Antioxidants Cause Melanoma to Metastasize Faster

By HospiMedica International staff writers
Posted on 20 Oct 2015
A new study suggests that antioxidant use can double the rate of melanoma metastasis in mice, reinforcing findings that indicate they can hasten the progression of lung cancer.

Researchers at Sahlgrenska Academy (Göteborg, Sweden) and the University of Gothenburg (Sweden) conducted a study in a murine model to examine the impact of using N-acetylcysteine (NAC, an antioxidant that is a specially modified form of the dietary amino acid cysteine), and the soluble vitamin E analog Trolox on progression of malignant melanoma. The study was launched following previous trials that showed that antioxidants actually increase cancer risk, and could even accelerate the progression of primary lung tumors.

The results showed that NAC increases lymph node metastases, but has no impact on number and size of primary tumors. Similarly, NAC and Trolox increase the migration and invasive properties of human malignant melanoma cells, but do not affect proliferation. Both increased the ratio between reduced and oxidized glutathione in melanoma cells and in lymph node metastases, with increased migration dependent on new glutathione synthesis. NAC and Trolox also increase activation of the small guanosine triphosphatase RHOA; blocking downstream RHOA signaling abolished antioxidant-induced migration. The study was published on October 7, 2015, in Science Translational Medicine.

“Taking nutritional supplements containing antioxidants may unintentionally hasten the progression of a small tumor or premalignant lesion, neither of which is possible to detect,” said senior author Prof. Martin Bergö, PhD, of the Sahlgrenska Academy. “Our current research combined with information from large clinical trials with antioxidants suggests that people who have been recently diagnosed with cancer should avoid such supplements."

Oxidation is a chemical reaction involving the loss of electrons or an increase in oxidation state, a process that can produce free radicals. As well-established, long term evidence shows that free radicals can cause cancer, many researchers thought that antioxidants, which destroy free radicals, could provide protection against the disease. Accordingly, antioxidants are found in many nutritional supplements, touted as a means of preventing cancer. Antioxidant use is particularly relevant in melanoma, not only because melanoma cells are known to be sensitive to free radicals, but because the cells can be exposed to antioxidants by non-dietary means as well.

Related Links:

Sahlgrenska Academy
University of Gothenburg



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Multilevel Self-Loading Stretcher
CARRERA XL

Latest Critical Care News

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants

First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD